Cargando…
Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p
Chronic inflammation plays a crucial role in vascular calcification. However, only a few studies have revealed the mechanisms underlying the development of inflammation under high-phosphate conditions in chronic kidney disease (CKD) patients. Here, we show that inflammation resulting from the activa...
Autores principales: | Li, Chao, Zhang, Shijun, Chen, Xiaoqing, Ji, Jingkang, Yang, Wenqing, Gui, Ting, Gai, Zhibo, Li, Yunlun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314757/ https://www.ncbi.nlm.nih.gov/pubmed/32581266 http://dx.doi.org/10.1038/s42003-020-1058-2 |
Ejemplares similares
-
Author Correction: Farnesoid X receptor activation inhibits TGFBR1/TAK1-mediated vascular inflammation and calcification via miR-135a-5p
por: Li, Chao, et al.
Publicado: (2020) -
Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
por: Li, Chao, et al.
Publicado: (2020) -
Antioxidant Effects of Protocatechuic Acid and Protocatechuic Aldehyde: Old Wine in a New Bottle
por: Zhang, Shijun, et al.
Publicado: (2021) -
miR-135a Suppresses Granulosa Cell Growth by Targeting Tgfbr1 and Ccnd2 during Folliculogenesis in Mice
por: Wang, Lei, et al.
Publicado: (2021) -
Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage
por: Gai, Zhibo, et al.
Publicado: (2017)